Bridgewater Associates’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,415
Closed -$375K 735
2024
Q4
$375K Sell
2,415
-1,049
-30% -$177K ﹤0.01% 605
2024
Q3
$631K Sell
3,464
-324
-9% -$48K ﹤0.01% 665
2024
Q2
$450K Sell
3,788
-836
-18% -$88K ﹤0.01% 761
2024
Q1
$496K Sell
4,624
-17,910
-79% -$1.78M ﹤0.01% 626
2023
Q4
$2.25M Buy
22,534
+17,769
+373% +$1.74M 0.01% 498
2023
Q3
$567K Sell
4,765
-16,095
-77% -$2.4M ﹤0.01% 676
2023
Q2
$3.72M Sell
20,860
-4,736
-19% -$869K 0.02% 361
2023
Q1
$4.22M Buy
25,596
+1,623
+7% +$279K 0.03% 342
2022
Q4
$3.78M Sell
23,973
-7,493
-24% -$1.14M 0.02% 414
2022
Q3
$4.74M Buy
+31,466
New +$5.24M 0.02% 390
2022
Q2
Sell
-32,369
Closed -$7.21M 1029
2022
Q1
$7.21M Buy
32,369
+10,282
+47% +$2.3M 0.03% 372
2021
Q4
$5.24M Buy
22,087
+2,496
+13% +$583K 0.03% 287
2021
Q3
$4.57M Sell
19,591
-1,721
-8% -$361K 0.03% 301
2021
Q2
$4.39M Buy
+21,312
New +$4.38M 0.03% 354

Other funds holding ICUI

Bridgewater Associates's ICUI Position: Q1 2025 in Review

Bridgewater Associates sold out of ICU Medical (ICUI) in Q1 2025, closing a stake of 2,415 shares — an estimated $375K sold.

Bridgewater Associates first reported a position in ICUI in Q2 2021 and held it in 14 quarters. The position peaked at $7.21M in Q1 2022. 281 funds tracked by Wall St. Rank hold ICUI as of Q1 2025.

  • Bridgewater Associates reported no remaining ICU Medical position as of Q1 2025 after selling out during the quarter.
  • Bridgewater Associates sold 2,415 ICU Medical shares in Q1 2025, an estimated $375K.
  • Bridgewater Associates first reported a position in ICU Medical in Q2 2021 and held it in 14 quarters.
  • Bridgewater Associates's ICU Medical position peaked at $7.21M in Q1 2022.
  • 281 funds tracked by Wall St. Rank held ICU Medical as of Q1 2025.

Based on Bridgewater Associates's 13F filing for Q1 2025, filed 14 May 2025.